Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,338,036
-
Total 13F shares
-
10,783,562
-
Share change
-
+919,769
-
Total reported value
-
$75,485,712
-
Price per share
-
$7.00
-
Number of holders
-
39
-
Value change
-
+$5,313,437
-
Number of buys
-
30
-
Number of sells
-
6
Institutional Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q2 2023
As of 30 Jun 2023,
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,783,562 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Boxer Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, and SVB Financial Group.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.